ProjectACT14820-Moves-PD
Basic data
Title:
ACT14820-Moves-PD
Duration:
01/05/2017 to 30/04/2022
Abstract / short description:
Multizentrische, randomisierte, doppelblinde, placebokontrollierte Studie zur Beurteilung der Wirksamkeit, Sicherheit, Pharmakokinetik und Pharmakodynamik von GZ/SAR402671 bei Patienten mit Morbus Parkinson im Frühstadium, die eine GBA-Mutation tragen
Involved staff
Managers
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Psychology
Faculty of Science
Faculty of Science
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Frankfurt am Main, Hessen, Germany